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AbstrAct
Phosphorylation of histone H2AX on serine 139 (γH2AX) is an early step in 
cellular response to a DNA double-strand break (DSB). γH2AX foci are generally 
regarded as markers of DSBs. A growing body of evidence demonstrates, however, 
that while induction of DSBs always brings about phosphorylation of histone H2AX, 
the reverse is not true - the presence of γH2AX foci should not be considered an 
unequivocal marker of DNA double-strand breaks. We studied DNA damage induced 
in A549 human lung adenocarcinoma cells by topoisomerase type I and II inhibitors 
(0.2 µM camptothecin, 10 µM etoposide or 0.2 µM mitoxantrone for 1 h), and using 3D 
high resolution quantitative confocal microscopy, assessed the number, size and the 
integrated intensity of immunofluorescence signals of individual γH2AX foci induced 
by these drugs. Also, investigated was spatial association between γH2AX foci and foci 
of 53BP1, the protein involved in DSB repair, both in relation to DNA replication sites 
(factories) as revealed by labeling nascent DNA with EdU. Extensive 3D and correlation 
data analysis demonstrated that γH2AX foci exhibit a wide range of sizes and levels 
of H2AX phosphorylation, and correlate differently with 53BP1 and DNA replication. 
This is the first report showing lack of a link between low level phosphorylation 
γH2AX sites and double-strand DNA breaks in cells exposed to topoisomerase I or II 
inhibitors. The data are discussed in terms of mechanisms that may be involved in 
formation of γH2AX sites of different sizes and intensities.
IntroductIon
Phosphorylation of histone H2AX on serine 139 
(γH2AX) is an early step in cellular response to DNA 
damage, when the damage results in formation of a 
double-strand break (DSB). Regions rich in γH2AX 
can extend over a stretch as long as 0.5 to 2 Mb, can 
be asymmetric in relation to a DSB, but do not cover 
the regions of active transcription [1] . γH2AX foci are 
readily detected by immunofluorescence microscopy 
and are generally regarded as markers of DSBs [2, 3]. A 
growing body of evidence demonstrates, however, that 
while induction of DSBs always leads to phosphorylation 
of histone H2AX, the opposite is not the case - the 
presence of γH2AX foci should not be considered 
unequivocal evidence of DSBs [4–11]. γH2AX 
foci exhibit a wide range of sizes and levels of the 
phosphorylated histone. This fact was generally assumed 
to reflect no more than an increasing or decreasing 
extent of H2AX phosphorylation at different time 
periods elapsing from the induction of a DSB, reflecting 
the kinetic progression or regression of individual 
γH2AX foci. Based on the data presented below, we 
suggest, however, that various sizes and brightness 
of immunostained γH2AX foci may reflect functional 
differences. We postulate that some small foci containing 
low levels of γH2AX may be formed in response to DNA 
lesions other than DSBs. 
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Here, we studied DNA damage and γH2AX 
foci induced by DNA topoisomerase inhibitors. It has 
been shown previously that camptothecin (CPT), a 
topoisomerase I (topo1) inhibitor, as well as mitoxantrone 
(MTX) and etoposide (ETP), topoisomerase II (topo2) 
inhibitors, induce DNA Damage Response (DDR) in a cell 
cycle-dependent manner. CPT induces DNA double-strand 
breaks (DSBs) and γH2AX exclusively in S-phase, at the 
sites of DNA replication [12–16]. Indeed, it is generally 
accepted that a collision of DNA replication forks with 
otherwise “cleavable” complexes of topo1 with DNA, 
but stabilized by topo1 inhibitor, leads to a collapse of the 
forks that triggers formation of a DSB [12–14, 16–19]. 
MTX also induces γH2AX preferentially (although with 
lesser exclusivity than CPT) in DNA replicating cells, and 
compared with CPT, with reduced selectivity for the sites 
of active DNA replication [16, 20]. However, a significant 
level of histone H2AX phosphorylation is seen also in cells 
that are not replicating DNA. Interestingly, although the 
level of γH2AX induced by MTX is significantly higher 
in S-phase than in nonreplicating cells, γH2AX, and 
presumably the DNA damage itself, do not necessarily 
occur in regions of active DNA replication, as we 
demonstrated previously [16, 20]. ETP presents a different 
case, in that it induces γH2AX foci in all phases of the cell 
cycle, with only weak preference to induce damage in DNA 
of replicating cells or at DNA replication sites [16, 20]. 
In this study we have turned our attention to three 
previous observations: (i) γH2AX foci induced by topo1 
and topo2 inhibitors in S-phase do not necessarily coincide 
with sites of DNA replication [16, 20]; (ii) γH2AX foci 
induced by these drugs exhibit a wide range of sizes and 
immunofluorescence intensities, and, consequently: (iii) 
some nuclear foci of H2AX phosphorylation are not 
spatially associated with 53BP1 (a factor involved in 
DSB repair [21, 22]) suggesting that they should not be 
unquestionably regarded as a marker of a DSB [4–11]. 
Thus, the goal of this work was to understand wheather 
γH2AX foci formed during an exposure to topoisomerase 
inhibitors are induced only in response to DSB, or 
whether they can be formed by other mechanism(s) 
involving interaction of the inhibitors with chromatin. 
Our working hypothesis assumed that γH2AX is not 
exclusively induced by the presence of DSBs. The small 
γH2AX foci containing low levels of γH2AX, unrelated 
to DNA replication and observed after treatment with 
camptothecin or mitoxantrone, are likely to be formed in 
response to drug-induced distortion of DNA structure or 
a change in torsional strain of the helix or the presence 
of single (template) strand DNA breaks formed by RNA 
polymerases elongating during transcription and colliding 
with the DNA-bound inhibitor [23]. In the case of DNA 
replicating cells they may possibly be reflecting DNA 
replication stress. To investigate this issue we have 
performed careful analysis of nearest neighbor distances, 
volumes and fluorescence intensities of foci rich in 
γH2AX or 53BP1, in relation to DNA replication sites 
(factories). This approach is based on the assumption that 
while the presence of γH2AX alone is not a sufficient 
proof of the existence of a DSB, the concurrent presence 
of both, γH2AX and 53BP1, the latter a factor thought to 
promote non-homologous end-joining-mediated (NHEJ) 
DSB repair, while preventing homologous recombination 
[24], is a strong indication, if not a sufficient piece of 
evidence, of a DSB presence in the focus. 
We describe here the associations between γH2AX, 
53BP1 and replication in subsequent phases of the cell 
cycle and subphases of S-phase, in a quantitative way, to 
demonstrate that a low level phosphorylation of histone 
H2AX on serine 139 is likely induced by stimuli other 
than DSBs, and is represented by small foci containing 
fewer γH2AX moieties than the prominent large foci, the 
latter most likely reporting the presence of DSBs. 
results 
In order to study γH2AX foci of various size and 
brightness we exposed A549 cells to CPT, MTX or ETP 
according to a protocol described in Figure 1A, and imaged 
foci of γH2AX, 53BP1 as well as DNA replication factories 
in cells in various sub-stages of S-phase (Figure 1B, 1C). 
The workflow of analysis is described in Figure 2. 
The number of γH2AX foci identified in cells incubated 
with each of the studied topoisomerase inhibitors was far 
greater than in untreated cells. Maximum z-projection 
images and 3D reconstructions, shown in Figure 3, 
convey the information about the overall density of 
foci of the three types, while the central cross-sections, 
shown in Supplementary Figure 1, reveal more clearly the 
characteristic patterns of replication foci in subsequent 
sub-stages of S-phase. The actual numbers of foci are given 
in Figure 4 and Supplementary Figure 3 (for all substages 
of S-phase; the particular substages were identified based 
on a characteristic pattern of spatial location of DNA 
replication sites, as described before [25, 26]). There 
was a great variation in sizes of the immunostained 
phosphorylated regions of chromatin, and a wide range of 
fluorescence brightness, a parameter, which is proportional 
to the amount of γH2AX in each focus (Supplementary 
Figure 2). In order to understand the link between DSBs 
and histone H2AX phosphorylation, in the context of 
DNA replication and the damage caused by topoisomerase 
inhibitors, we analyzed the positions of γH2AX foci in 
relation to the foci of 53BP1 and DNA replication sites. 
The data analysis entailed subdivision of γH2AX foci into 
two classes, as shown schematically in Figure 2A. The 
first class (“bright” foci) embraced foci of a large size or 
brightness (at least 0.25 μm3 volume or at least 35 gray 
levels in 8-bit scale mean fluorescence intensity images), 
while the second (“dim” foci) included small size and low 
brightness foci (less than 0.25 μm3 volume and less than 
35 gray levels). Figure 5 shows an example of a maximum 
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intensity projection of a raw image of γH2AX and the 
assignment of foci to the respective classes, in untreated 
and CPT-treated cells. We have analyzed the positions of 
γH2AX foci in relation to regions of replication and foci 
of 53BP1, as described below. 
endogenous (constitutive) H2AX 
phosphorylation
We first analyzed ‘bright’ γH2AX foci in untreated 
cells, thought to report predominantly DNA damage 
induced by endogenous oxidants [27]. In untreated S-phase 
cells the number of “bright” γH2AX foci correlated weakly 
with the number of DNA replication sites (Figure 4A, 
Supplementary Figure 3A). The histograms of distances 
between “bright” γH2AX foci and replication factories 
(Figures 6A, 6E, and Supplementary Figure 4 (untreated)) 
demonstrated that there was no definite preference 
for γH2AX foci to occur at an immediate vicinity of 
replicating DNA. Almost all “bright” γH2AX foci had a 
closely associated 53BP1 focus, suggesting their presence 
at the sites of DSBs (Figures 7A, 7E, and Supplementary 
Figure 5 (untreated)). These observations imply that the 
“bright” γH2AX foci in untreated cells represent DSBs. 
Figure 1: experimental design and patterns of dnA replication in A549 cells. (A) Experimental schedule. DNA precursor 
EdU was added to culture medium at time 0. 30 minutes later a topoisomerase inhibitor was introduced for 60 minutes, still in the presence 
of EdU. After replacing medium cells were incubated under standard conditions for 1 h to allow histone H2AX phosphorylation, and fixed. 
(b) Confocal images of characteristic patterns of replication factories in subsequent sub-stages of S-phase. S-phase was divided into 5 
distinct sub-stages, according to the number and distribution of active replication regions. Note that the duration of these subphases of S 
varied substantially. Upper row – images of single, equatorial focal planes reveal typical replication patterns, lower row – maximum intensity 
projections of the whole nucleus (z-stacks); this image representation enables visual estimation of the overall density of fluorescence 
signals. All images were deconvolved and normalized, therefore, in this form, they do not reflect the total amount of the incorporated EdU. 
Scale bar 5 μm. (c) Timeline of replication in A549 cells, divided into 5 sub-stages, based on live cell imaging of eGFP-PCNA.
Figure 2: Workflow of 3D data analysis. (A) Segmentation of fluorescence signals in 3D images. In each detection channel (EdU, 
γH2AX and 53BP1) coordinates and the number of local intensity maxima representing separate foci are determined. For γH2AX channel the 
volume and intensity values are computed for each focus in order to classify foci as “dim” or “bright” (see the text for definition). The complete 
dataset embracing the analysis of volumes and intensities in non-replicating cells and in all sub-stages of S-phase is presented in Supplementary 
Figure 2. Scale bar 5 μm. (b) Nearest neighbor analysis in 3D datasets. The nearest neighbor distances are presented as histograms. 
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However, the shape of the histogram (Figure 7A, 7E) 
and the correlation analysis (Supplementary Figure 7 
(untreated)) indicate that there might be a minor tendency 
of γH2AX foci to be associated with DNA replication. 
Thus, the probability of induction of DSB by endogenous 
factors in replicating regions are only slightly higher than 
in the sites of DNA that do not undergo replication. This 
assessment agrees with our previous observations [16]. 
The number of “dim” γH2AX foci in untreated 
cells was far greater than the “bright” ones (Figure 4A, 
Supplementary Figure 3A). In the case of DNA replicating 
cells their number approximately correlated with the 
number of DNA replication sites. However, there was 
no apparent proximity between these sites in 3D space. 
Specifically, the ‘dim” γH2AX foci, although very 
numerous in S-phase, appeared not to be preferentially 
located at-, or near- replicating DNA (Figures 6A, 6E, 
Supplementary Figure 3, and Supplementary Figure 4 
(untreated)). They were not associated with 53BP1 
either (Figures 7A, 7E, Supplementary Figure 3 and 
Supplementary Figure 5 (untreated)). We conclude that 
the “dim” γH2AX do not represent DSBs, and may be 
marking other type of DNA lesions. 
Histone H2AX phosphorylation induced 
by topoisomerase inhibitors - the “bright” 
γH2AX foci
Phosphorylation of H2AX foci induced by the three 
topoisomerase inhibitors varied in size and brightness 
(Supplementary Figure 2). The “bright” and the “dim” foci 
were analyzed separately. 
Figure 3: 3D images of cell nuclei showing the distribution of replication factories, foci of γH2AX and 53BP1, following 
exposure to topoisomerase I and II inhibitors. Overlapping replication (green - EdU) with DNA damage response (red - γH2AX, 
blue – 53BP1) regions indicates selectivity of DNA damage induction towards active regions of replication. Maximum intensity z-projections 
of confocal stacks following deconvolution and normalization (A), enlarged selected areas (b), 3D maximum intensity xyz images (c), and 
xz (d) projections are shown.
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camptothecin
The numbers of “bright” γH2AX foci induced 
by CPT correlated with the numbers of DNA 
replication foci (Figure 4D, Supplementary Figure 3D) 
and were significantly greater in S-phase than in the cells 
not replicating DNA (Supplementary Figure 2 (CPT) 
and 3D). The “bright” γH2AX foci were located in a close 
proximity to DNA replication factories (Figure 6D, 6H and 
Supplementary Figure 4 (CPT)) and a large proportion of 
these foci (especially in late S-phase) were associated with 
53BP1 (Figure 7H, images “CPT” and Supplementary 
Figure 5 (CPT)). Therefore these foci were most likely 
representing DSBs. We hypothesize that a subpopulation 
of “bright” γH2AX foci that were not associated with 
53BP1 represented the sites of newly induced DSBs, 
where the repair process involving recruitment of 53BP1 
did not yet commence at the time of cell fixation. These 
observations are in agreement with the already published 
data that CPT induces DSBs and DDR in replicating 
regions of DNA [16]. We conclude that a very large 
proportion, if not all “bright” γH2AX foci detected in 
S-phase in CPT-treated cells represent DSBs. 
Mitoxantrone
MTX also induced “bright” γH2AX foci 
(Supplementary Figure 3 (MTX)), and their number 
correlated with the number of replication factories, especially 
in early and mid S-phase (Figure 4C, Supplementary 
Figure 3C). However there was no obvious preference for 
“bright” γH2AX foci to be located in or near DNA replication 
sites (Figure 6C, 6G). A large subpopulation of γH2AX foci 
were located within or adjacent to 53BP1 (Figure 7C, 7G, 
and Supplementary Figure 5 (MTX)), suggesting that 
these foci corresponded to DSBs. As in the case of CPT, 
however, there was also a large number of γH2AX foci 
not accompanied by 53BP1. In summary, although MTX 
showed a propensity to induce DSBs in S-phase cells, and 
caused formation of large γH2AX foci, unlike CPT, these 
lesions were not linked directly to DNA replication sites. 
etoposide
The number of “bright” γH2AX foci in the 
cells treated with ETP was relatively low (Figure 4B, 
Supplementary Figure 3B, Supplementary Figure 2 
(ETP)). Most of these foci correlated with 53BP1 
(Figure 7B, 7F and Supplementary Figure 5 (ETP)) 
but not with DNA replication sites (Figure 6B, 6F and 
Supplementary Figure 4 (ETP)). This is an indication 
that they represented DSBs, but with no direct link to 
replication. Most of the γH2AX signal induced by ETP 
was associated with the “dim” foci that were almost 
entirely located at a distance from DNA replication 
regions, as discussed below. 
Histone H2AX phosphorylation induced by 
topoisomerase inhibitors - the “dim” γH2AX foci
Interestingly the analysis of the “dim” and “bright” 
γH2AX foci induced during exposure to topoisomerase 
inhibitors demonstrated that, in general, the positions of 
these foci were different in relation to replication factories 
and 53BP1 foci (Figure 6, Figure 7). Specifically, unlike 
the “bright” foci, the “dim” γH2AX foci revealed no clear 
association, with 53BP1 or with DNA replication. 
camptothecin
The most conspicuous case of “dim” γH2AX 
foci is presented by exposure to CPT. Here the “dim” 
γH2AX foci were numerous but exhibited neither 
proximity to replication sites nor to 53BP1 foci 
(Figure 6D, 6H, Supplementary Figure 4 (CPT), Figure 
7D, 7H and Supplementary Figure 5 (CPT), respectively). 
Only a very small proportion of the “dim” foci was 
associated with 53BP1, suggesting that these particular 
foci may have been in an early stage of histone H2AX 
phosphorylation induced by a DSB. However, the majority 
of “dim” γH2AX foci were not associated with 53BP1 or 
replication, suggesting that they did not represent DSBs. 
Since the mechanism of DNA damage induced by CPT in 
DNA undergoing replication is known in detail [17, 18, 28], 
and we are not aware of any evidence of CPT inducing 
DSBs that would be marked by γH2AX outside of the 
replicating DNA, the presence of “dim” γH2AX in regions 
distant from replication and devoid of 53BP1 speaks in 
favor of a notion that the low level H2AX phosphorylation 
is unrelated to the presence of DSBs. This statement is 
corroborated by the fact that we observed a statistically 
significant increase of “dim” γH2AX foci when non-
replicating A549 cells were challenged with CPT 
(Figure 4D, nonreplicating cells and Supplementary 
Figure 2D). We have seen a similar phenomenon in 
HeLa cells and in normal human fibroblasts derived from 
healthy donors and grown in culture (data not shown). 
Thus, the available evidence suggests that these γH2AX 
signals must have been induced by mechanism(s) other 
than formation of DSBs. 
It is important to note that the number of detectable 
“dim” γH2AX foci was generally lower in replicating 
cells treated with CPT or MTX, and higher in replicating 
cells exposed to ETP, or in the untreated controls. This 
difference is, at least in part, due to the fact that “bright” 
γH2AX foci in DNA replicating cells are very numerous 
after exposure to CPT or MTX, therefore their 3D 
images occupy a large proportion of the available space 
and overshadow the small “dim” foci. Thus, because 
of this hindrance, in samples with a high number of 
”bright” γH2AX foci, the number of “dim” foci was 
underestimated. Since the density of foci of various classes 
influences the probability of their accidental overlap 
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Figure 4: Images of nuclei (max. int. z projections) in early, mid and late S, and the average numbers of replication (EdU) and 
DDR (γH2AX, 53BP1) foci in cells exposed to topoisomerase inhibitors. Each bar is based on determination of foci numbers in ca. 20 
nuclei. Note, that in cells that suffered heavy damage the density of γH2AX foci is high, therefore the number of “dim” γH2AX foci is 
underrepresented. A complete statistical analysis of the numbers of foci is included in Supplementary Figure 3.
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including the mean distances between foci of two types, 
and, consequently influences the shapes of the histograms 
of these distances, we have also preformed correlation 
analysis, using the approach, which was mathematically 
defined in detail previously [20]. 
Analysis of normalized autocorrelation functions 
of the “bright” γH2AX foci revealed their non-random 
clustering (L > 0) in cells treated with CPT and ETP, at 
distances shorter than 1 μm (Supplementary Figure 6F and 
6H, respectively). This effect is most prominent in late S 
(ETP: S-IV yellow line, ETP and CPT: S-V red line). On 
the other hand, no clusters were observed in cells treated 
with MTX (Supplementary Figure 6G). In untreated cells 
constitutive (endogenous) “bright” γH2AX foci tended to 
form clusters in all subphases, since the primary sites of 
damage were DNA replication foci containing multiple 
active replication forks (Supplementary Figure 6E). Note, 
that the number of foci analyzed in untreated cells was 
very low. Moreover, the clustering of “bright” γH2AX 
foci in the control and the CPT or ETP treated cells was 
independent of the distribution of DNA replication sites. 
Thus, it can be speculated that the grouping of “bright” 
γH2AX foci was not determined by this process. It may 
also be noted that a similar pattern of clustering was 
detectable in the case of 53BP1 foci (Supplementary 
Figure 6M–6P). Regardless of the treatment and the sub-
stage of S-phase autocorrelation (L) function values of 
“dim” γH2AX foci were close to 0 (at all distances), which 
indicated their uniform distribution. 
Analysis of normalized cross-correlation (L) 
function revealed that, in cells treated with CPT, 
replication and “bright” γH2AX foci coincided at 
distances shorter than 0.5 μm (Supplementary Figure 7D). 
This effect was reflected in the values of L-function being 
larger than 0 (random correlation) and was most prominent 
in the late S-phase. In control cells the correlation was 
weaker, but clearly detectable in the late S. In the case 
of cells treated with ETP and MTX, correlation between 
CPT “bright” γH2AX foci was less pronounced and 
detectable (i.e. non-random) at distances shorter than 
0.3 μm. This is likely to reflect a non-uniform distribution 
of nuclear chromatin density, while the calculations of 
random correlation values were based on the assumption 
of uniformity (see Materials and Methods). Likewise, a 
strong correlation between the “bright” γH2AX foci and 
53BP1 at distances shorter than 0.5 μm was detectable 
in cells treated with CPT, ETP and in the untreated cells 
(Supplementary Figure 7I–7L). This correlation was less 
pronounced in the cells treated with MTX, though. 
No significant correlation between replication regions 
and “dim” γH2AX foci was observed in cells treated with 
topoisomerase II inhibitors (ETP and MTX) and in control 
(Supplementary Figure 7E–7G). On the other hand some 
degree of correlation between these signals was detected 
Figure 5: “Bright” and “dim” γH2AX foci. Maximum intensity projection images, and histograms of raw 3D image stacks (enhanced 
by increasing the brightness), and the processed images of the same areas, displayed by using color-coded classification for “bright” and 
“dim” γH2AX. 
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(particularly in S-IV subphase) in cells treated with CPT 
(Supplementary Figure 7H). This notion is compatible 
with the results of the nearest neighbor analysis. One 
may postulate that, in contrast to the effects of ETP and 
MTX, the population of “dim” γH2AX foci (CPT) 
was heterogeneous and some of the foci correspond to 
replication-associated DNA lesions. Likewise, in the treated 
cells correlation between the “dim” γH2AX foci and 53BP1 
foci was slightly stronger in the case of CPT than in the case 
of ETP and MTX (Figure 7N–7P). Nonetheless, in all these 
cases the strength of the “dim” γH2AX foci correlation was 
significantly lower than the respective value calculated for 
their “bright” counterparts. In summary, we conclude that 
correlation analysis confirmed the association between the 
“bright” γH2AX foci and DNA replication sites and 53BP1 
foci, and a lack of such an association between the “dim” 
foci and DNA replication (Supplementary Figure 6 and 
Supplementary Figure 7). 
Mitoxantrone
The number of “dim” γH2AX foci in MTX treated 
cells correlated with the number of replication foci and was 
similar (in early S) or lower (in mid and late S) than the 
number of “bright” foci (Figure 4C, Supplementary Figure 
3C). The same rule applied – the “dim” foci were not 
located close to the replication factories (Figure 6C, 6G and 
Supplementary Figure 4 (MTX)), nor did they have 53BP1 
associated with them (Figure 7C, 7G and Supplementary 
Figure 5 (MTX)). This observation, again, supports the 
notion that the “dim” γH2AX foci were unrelated to DSBs. 
etoposide
In the case of ETP the number of “dim” γH2AX 
foci was much greater than of “bright” foci (Figure 4B, 
Supplementary Figure 3B) and the “dim” foci did not 
coincide with replication factories (Figure 6B, 6F and 
Supplementary Figure 7 (ETP)). While only very few ETP-
induced “dim” γH2AX foci were associated with 53BP1 
most of them were located afar of 53BP1 (Figure 7B, 7F, 
and Supplementary Figure 5 (ETP)), suggesting that this 
widespread but weak phosphorylation of histone H2AX 
was not representing DSBs. 
dIscussIon
It is now generally accepted that mammalian cells 
respond to induction of DSBs by phosphorylation of 
histone H2AX in nucleosomes located over long stretches 
of DNA on both flanks of the break [1–3]. It appears that 
despite occasional exceptions, a reverse statement has 
also been well entrenched by now – that of γH2AX being 
a specific marker for DSBs. However, several reports 
demonstrated that γH2AX may also occur in chromatin 
regions that do not harbor DSBs marked with 53BP1, and 
can be induced by hydrogen peroxide [11], UV irradiation 
[9], or other stimuli [29]. Such γH2AX foci were observed 
in senescent cells [4], mitotic cells [7] and in mouse 
embryos [8]. Interestingly, it has also been demonstrated 
that phosphorylation of H2AX can be initiated by a 
stimulus, which is not necessarily a damage event itself 
[30]. We also note, however, that although in several 
reported cases γH2AX was not directly linked to DSBs, 
the presence of such DNA breaks could not be ruled out, 
as discussed in [31]. 
The fact that γH2AX foci detected by 
immunofluorescence come in a variety of sizes and 
intensities was often explained as due to kinetics of their 
regression as a function of time following their induction 
by the DSB. Here we present quantitative analysis of 
sizes of these foci, the levels of phosphorylation, position 
relative to foci containing 53BP1 (a protein, which is 
involved in DSB repair), and DNA replication sites to 
substantiate our assertion that γH2AX foci that are small 
in size and contain low levels of the phosphorylated 
histone H2AX are formed in response to DNA damage or 
stress but not the presence of DSBs.
As this notion contradicts the generally established 
(even if questioned already [4–11]) opinion, the most 
likely interpretation of the presence of “dim” γH2AX foci 
is likely to center on a suspicion that they simply represent 
either a time-related regression of the large bright foci, a 
technical artifact, certain kind of nonspecific staining, or 
noise. Indeed, in our previous work we (and presumably 
other labs interested in γH2AX imaging) assumed that 
low level of phosphorylation or small (‘dim’) γH2AX 
foci should be classified as a “background” or a certain 
kind of staining of unspecified mechanism. A known 
molecular mechanism of DSB induction by camptothecin 
[12–14], a priori knowledge regarding the induction of 
DNA strand breaks by topoisomerase inhibitors detected 
by the TUNEL assay [32], careful optimization of labeling 
procedures and quantitative analysis, as done in the 
present study, lead us to propose, that these ‘dim’ foci may 
have a possible functional significance, although of a still 
unidentified nature. 
Low intensity γH2AX immunofluorescence may 
adopt a form of a relatively uniform level of evenly 
distributed staining or small foci characterized by 
fluorescence levels only slightly exceeding the noise 
level. Their appearance is dependent on the quality of 
immunofluorescence staining, the type of the objective 
lens used, and the image processing techniques leading 
to a final image. We note the fact that several nuclear 
proteins we studied look as uniformly distributed in a live 
cell image of an FP-tagged fusion protein, but appear as 
grainy or dotty after fixation and immunofluorescence 
detection of the endogenous or the fusion protein. Even 
if the subnuclear distribution of γH2AX (more uniform 
or more foci-like) is contested, this does not alter the final 
conclusion of the reasoning presented here. Whether the 
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low level phosphorylation is induced in a form of small 
foci or of somewhat larger sites, in both cases we do not 
observe any association with 53BP1 or DNA replication 
factories. If γH2AX were associated with DSBs only, 
such an association should be present, and it should be 
close to a 1-to-1 relationship. A high correlation between 
γH2AX and 53BP1 is found only in the case of ”bright”, 
but not the “dim” foci γH2AX foci in CPT-treated cells in 
S-phase. 
Further arguments in favor of the notion that the 
minor phosphorylation sites do not constitute a nonspecific 
background, a technical artifact, or a phenomenon related 
to DSBs, are based on the following observations:
1.  The number of “dim” γH2AX foci increases 
as cells move from G1 into S-phase in control, 
untreated cells. The signal representing 
nonspecific binding of the secondary antibody, 
which is used to detect γH2AX, is not expected 
to depend on the level of replication,
2.  There is a statistically significant higher number 
of “dim” γH2AX foci in CPT-treated cells that 
do not replicate DNA, than in untreated ones. 
CPT is not expected to induce DSB in cells not 
replicating DNA, thus the “dim” γH2AX foci 
in such cells can reasonably be interpreted as a 
chromatin modification unrelated to DSBs, yet 
still associated with a CPT insult,
3.  The majority of “dim” γH2AX foci are not 
located close to 53BP1 or DNA replication 
sites, while the “bright” γH2AX foci are mostly 
associated with DNA replication (in CPT or 
MTX treated cells). If “dim” γH2AX were just 
representing an early stage of phosphorylation 
at DSB sites, 53BP1 would be expected to be 
present in (at least) some of these sites as well. 
No such correlation was seen, 
4.  If the ‘dim” γH2AX foci were marking DSBs 
induced at the sites of DNA replication in a very 
early stage of S-phase, incorporation of some 
EdU would be detected at these sites. We, as well 
as others, have shown that EdU is a sensitive 
marker of replication, with no detectable 
nonspecific staining or background [33]. Our 
microscopy system is capable of detecting DNA 
replication with high sensitivity, therefore the rate 
of false negative identification of S-phase cells is 
very low if any. No EdU signals associated with 
“dim” γH2AX were detected.
The arguments presented above essentially exclude 
the possibility that the “dim” foci are the markers of DSBs. 
The question may be asked therefore what kind of DNA 
or chromatin lesions may generate them. The following 
events may be accountable for it:
untreated cells
It is likely that in the case of the untreated, control 
cells the reactive oxygen species (ROS) generated 
during oxidative phosphorylation are responsible for 
the “constitutive H2AX phosphorylation” as described 
by us before [27]. Consistent with the current findings 
we observed then an increased intensity of γH2AX 
immunofluorescence in the S-phase cells as compared with 
G1 cells. γH2AX immunofluorescence of these cells was 
Figure 6: Histograms of distances from “bright” or “dim” γH2AX foci to the nearest region of replication (EdU). 
Distances from each γH2AX focus of either class (“bright” or “dim”) to the nearest replication (EdU) site have been measured. Data for 
foci in very early S (S-I, replication of euchromatin) and late S (S-IV, replication of heterochromatin) are shown. The median value of the 
distance is given in the upper right corner of each panel. Each histogram represents the averaged data based on at least 20 nuclei per class. 
The complete analysis of all sub-stages of S-phase is given in Supplementary Figure 4.
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decreased by over 50% by the short (1 h) cells exposure 
to the classical ROS scavenger N-acetyl-L-cysteine [27].
CPT-treated cells
CPT binds to both topo1 and DNA with hydrogen 
bonds stabilizing, the otherwise transient, covalent topo1-
DNA complex [34, 35]. This prevents DNA re-ligation and 
therefore causes DNA damage that results in apoptosis. 
The latter however occurs only when DNA replication 
forks collide with the stabilized complexes [18]. However, 
because we did not see the spatial association between the 
EdU incorporation and the “dim” foci it is likely that just 
stabilization of the covalent topo 1 and DNA complexes may 
be recognized by the cell as the lesion that can trigger H2AX 
phosphorylation leading to formation of the “dim” foci.
MtX-treated cells
The anthracycline antibiotic MTX, binds to DNA 
by intercalation elongating the ds DNA helical structure 
[36, 37]. Furthermore, it also has an ability to condense 
nucleic acids, including DNA, with an affinity related to 
DNA bases composition [38]. Thus, in the case of cells not 
replicating DNA these modes of deformation of the double 
helix may lead to an induction of H2AX phosphorylation 
in form of the “dim” foci. It should also be noted that 
although MTX was introduced to substitute its analogue 
doxorubicin because of toxicity (cardiotoxicity) of the 
latter related due to induction of oxidative stress, although 
being much less toxic, MTX also generates ROS after 
binding to cells [39]. 
Figure 7: Maximum intensity projection images and histograms of distances from “bright” or “dim” γH2AX foci to 
the nearest 53BP1 focus. Data for foci in very early S (S-I, replication of euchromatin) and late S (S-IV, replication of heterochromatin) 
are shown. The median value of the distance is given in the upper right corner of each panel. Each histogram represents the averaged 
data based on at least 20 nuclei per sub-stage of S-phase. Complete analysis corresponding to every sub-stage of S-phase is given in 
Supplementary Figure 5. 
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ETP-treated cells
ETP inhibits the re-ligation reaction of topo2 after 
it nicks the two strands of DNA, trapping it in a cleavable 
complex consisting of two topo2 subunits covalently 
linked to the 5′ ends of DNA. Because the two subunits 
interact strongly with each other to hold the two ends of 
DNA together this structure is not directly recognized 
as a true DSB by cells [40–42]. Furthermore ETP was 
shown to have higher affinity to chromatin compared to 
DNA and that the globular domain of histones was the site 
of its binding [43]. This binding of ETP to histones was 
shown to alter their secondary structure accompanied with 
hypochromicity revealing compaction of histones in the 
presence of the drug [43]. The both types of interaction 
of ETP, either with DNA and/or with chromatin, may be 
responsible for the presently observed induction of the 
“dim” γH2AX foci. 
Needless to say, the constitutive phosphorylation 
of H2AX as reported in the case of untreated, control 
cells and related to the production of oxidative species 
by mitochondria [27] and presently seen in our untreated 
cells, likely contributed to the formation of “dim” γH2AX 
foci in the CPT-, MTX- as well ETP- treated cells. 
It should be noted that in addition to the effect of 
topoisomerase inhibitors on DNA replication, as discussed 
above, also their impact on transcription may play a role 
in inducing H2AX phosphorylation that can lead to the 
“dim” foci. It was shown that DNA breaks resulting from 
collision of elongating RNA polymerase with the inhibitor-
DNA binding sites take place only on a single (template) 
DNA strand whereas the non-template strand within the 
transcription bubble remains intact [23, 44]. It is likely 
therefore, that the “dim” γH2AX foci observed by us may 
also mark the ssDNA breaks occurring as a consequence 
of a collision of elongating RNA polymerase with the 
DNA-inhibitor sites [28]. This mechanism is consistent 
with the observation that the “dim” foci were seen in 
the cells treated with the DNA binding topoisomerase 
inhibitors CPT or MTX but not in the cells treated with 
the topo2-binding ETP. In support of this mechanism 
are also observations that short treatment of A549 cells 
with 2 or 20 nM MTX dramatically decreases the rate of 
transcription, an evidence of formation of MTX-DNA 
complexes that stop progression of RNA polymerase [44]. 
MAterIAls And MetHods
cell cultures and drug treatment
A549 human lung adenocarcinoma cells were 
obtained from ATCC and maintained as described 
previously [26]. Exposures to the drugs were commenced 
24–48 h after seeding, when cells were in the exponential 
phase of growth and reached approximately 70% 
confluency. In order to fluorescently label nascent DNA 
synthesized prior to an exposure to a topoisomerase 
inhibitor, a DNA precursor (EdU, 10 μM, Molecular 
Probes/Thermo Fisher Scientific) was added to culture 
medium 30 minutes before exposure to the drug [45]. 
The drug exposure lasted for 1 h, in the presence of EdU 
(0.2 µM CPT , Sigma-Aldrich; 10 µM ETP, Sigma-Aldrich; 
or 0.2 µM MTX, Hospira). After the drug treatment culture 
medium was removed, cells were washed twice with a pre-
warmed PBS, and incubated in fresh culture medium for 
1 h. Subsequently cells were washed with PBS again and 
fixed with formaldehyde (4%, methanol free, at RT, for 15 
min, Electron Microscopy Sciences (Figure 1A)). 
staining procedure
Before immuno-labeling, cells were permeabilized 
with 0.5% Triton-X 100 and blocked overnight with 
BSA (3%, w/v) in moist chamber in 4°C. DNA damage 
response and repair of double strand breaks (DSB) were 
detected by fluorescence immunostaining of γH2AX 
[2] and of 53BP1. A mixture of primary antibodies was 
applied for 1 h, at RT (phospho-specific γH2AX mAb - 
1:350 dilution, Millipore, cat no. 05-636; 53BP1 IgG - 
1:200 dilution, Abcam, cat. no. ab21083). After washing, 
cells were incubated for 1 h with a mixture of secondary 
antibodies (goat anti-mouse IgG (H+L) AlexaFluor555 – 
1:1000, Molecular Probes/Thermo Fisher Scientific, cat. 
no. B00079; and goat anti-rabbit IgG (H+L) and 1:2000 
dilution of AlexaFluor488 – 1:2000, Molecular Probes/
Thermo Fisher Scientific, cat. no. B00072). After each 
incubation cells were washed gently with PBS with Ca2+ 
and Mg2+ for at least 1 h with 7 or more replacements of 
the washing solution. Care was taken not to allow the 
sample to dry. 
In order to label newly replicated chromatin, 
incorporation of EdU, followed by ‘click’ reaction 
with a fluorescent label was performed (Click-iT® EdU 
AlexaFluor647N Imaging Kit; Molecular Probes/ Thermo 
Fisher Scientific). The labeling procedure was carried out 
according to the manufacturer instructions. After labeling, 
samples were mounted on glass slides using ProLong Gold 
Antifade Mountant (Molecular Probes/Thermo Fisher 
Scientific). 
confocal imaging
Leica TCS SP5 confocal system (Leica 
Microsystems GmbH, Wetzlar, Germany) was used to 
image fixed cells. The following instrumental parameters 
were used: 63× HCX PL APO CS NA 1.4 oil immersion 
lens, confocal iris set at 1 Airy disc, excitation 488 nm 
(Ar laser), 561 nm (DPSS laser) and 633 nm (HeNe 
laser), emission detection bands 500–550 nm for 
AlexaFluor488 (immunofluorescence of 53BP1), 570–620 
nm for AlexaFluor555 (immunofluorescence of γH2AX) 
and 660–720 nm for AlexaFluor647N (EdU Click-iT 
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detection). Registration was performed in sequential 
mode, with a scanning rate of 8000 Hz (resonant scanner), 
8 bit dynamic range, with 16 averaged frames for one 
confocal plane. One 3D stack consisted of at least 80 
confocal slices, confocal planes (512 × 512 pixels, pixel 
size 60 nm) were separated by 130 nm along z axis. 
Image processing and quantitative image analysis 
3D images were deconvolved using Huygens 
Deconvolution & Analysis Software (Scientific Volume 
Imaging B.V., Hilversum, Netherlands). Quantitative 
analysis of the deconvolved images representing 
replication factories or γH2AX or 53BP1 foci was used 
to determine their position, number and volume. Raw 
images were used to estimate mean fluorescence intensity 
of individual γH2AX foci. 
The analysis was carried out with the use of algorithms 
developed under ImageJ macro language and Python. Prior 
to estimation of foci position, deconvolved stacks were 
corrected for registration shift and oversaturated pixels. 
Local fluorescence maxima within foci were designated 
using 3D max finder software [16]. Briefly, coordinates were 
calculated as the conjunction of two individual searches in 
orthogonal sections with the use of ImageJ plugin ‘Find 
Maxima’. Search parameters based on foci density and 
background level were optimized for each single nucleus 
by human expert. Determination of the parameters was 
unbiased by drug treatment or the classification of the sub-
stage of the S phase of the cell cycle. Estimation of the foci 
volume was based on an iterative flooding of the maxima 
in 3D space as described previously in [26]. Classification 
of γH2AX foci into two classes was based on foci volume 
and mean fluorescence intensity in raw images, prior to 
deconvolution. Foci of a volume over 0.25 μm3 or a mean 
intensity over 35 a.u. were classified as ”bright” foci. The 
foci characterized by a lower volume and fluorescence 
intensity were classified as ‘dim’ (Supplementary Figure 2).
The set of all distances from all γH2AX foci to 
their nearest replication factory or 53BP1 focus were used 
to construct a histogram of the distances to the nearest-
neighbor. This procedure was repeated for each nucleus, 
as described previously [16, 20].
Relationship (spatial correlation) of positions 
of γH2AX foci and replication or 53BP1 foci was 
characterized over a range of distances using normalized 
Ripley’s K functions (L-functions). The functions were 
calculated for each nucleus. Detailed description of 
the algorithm was given in our previous paper [16, 20]. 
Briefly, value of L = 0 corresponds to random association 
(proximity) of signals at a given distance, whereas a value 
L > 0 indicates their non-random association. Thus, L = 1 
indicates that the number of pairs of foci (at a given 
distance) exceeds the respective value obtained for 
their random distribution by factor of 100%. Difference 
between the distribution average and 0 was tested at each 
point (distance) which constitutes the L-function. One 
should note that the value of L-function may be slightly 
overestimated at short distances, owing to non-random 
distribution of nuclear chromatin. 
An independent student’s t-test was used in statistical 
analysis, using a value of t < 0.05 as a measure of 
significance. The number of nuclei analyzed for each drug 
treatment in each sub-stage of S phase was at least 18 (the 
exact numbers are provided in Supplementary Figure 3). 
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